Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal capsule endoscopy for evaluation of patients with chronic gastroesophageal reflux symptoms: findings and its image quality.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2011
Same author

On the Co-Operation of the Fibrous Pericardium with the Ventricles, in Accelerating the Flow of Blood into the Auricles.

Provincial medical & surgical journal·2010
Same author

Measurement, reconstruction, and flow-field computation of the human pharynx with application to sleep apnea.

IEEE transactions on bio-medical engineering·2010
Same author

Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects.

Alimentary pharmacology & therapeutics·2003
Same author

Duodenal duplication cyst.

Endoscopy·2002
Same author

Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization.

Neuroscience·2002

Related Experiment Video

Updated: Jun 23, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

A new look at peptic ulcer.

M I Grossman, P H Guth, J I Isenberg

    Annals of Internal Medicine
    |January 11, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Recent peptic ulcer research reveals new causes like gastrinomas and identifies duodenal ulcer defects. Novel drugs and surgical techniques are being evaluated for improved treatment outcomes.

    More Related Videos

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
    05:50

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation

    Published on: September 22, 2023

    Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
    03:05

    Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

    Published on: February 16, 2024

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
    06:40

    The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

    Published on: June 29, 2019

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
    05:50

    Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation

    Published on: September 22, 2023

    Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
    03:05

    Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

    Published on: February 16, 2024

    Area of Science:

    • Gastroenterology
    • Internal Medicine
    • Surgical Innovation

    Background:

    • Peptic ulcers remain a significant health concern with evolving understanding of their etiology.
    • Recent research has illuminated rare causes, such as gastrin-producing tumors (gastrinomas).
    • Physiological defects in duodenal ulcer disease include altered gastrin regulation and reduced acid inhibition.

    Purpose of the Study:

    • To review recent advances in understanding peptic ulcer disease.
    • To highlight novel therapeutic approaches, including pharmacologic and surgical interventions.
    • To discuss the pathogenetic significance of duodenal reflux in gastric ulcers.

    Main Methods:

    • Review of recent scientific literature on peptic ulcer disease.
    • Assessment of new drug classes targeting acid secretion (prostaglandins, histamine analogues).
    • Evaluation of a novel surgical technique for duodenal ulcer treatment.

    Main Results:

    • Gastrin-producing tumors identified as a rare cause of peptic ulcers.
    • Multiple physiological defects found in duodenal ulcer patients.
    • New drug classes show strong acid inhibition; clinical trials are ongoing.
    • A selective vagotomy procedure for duodenal ulcers demonstrates promise.

    Conclusions:

    • Advances in understanding peptic ulcer pathophysiology are leading to innovative treatments.
    • New pharmacologic agents and surgical techniques offer potential for improved patient outcomes.
    • Further clinical trials are essential to validate the efficacy of novel therapies.